Scion Asset Management, LLC sold REGN · INSIDER
Data sources SEC Form 4 1h ago
House PTR 1h ago
SEC 13F 1h ago
Robinhood Chain 1h ago
SEC 13F / EXIT Verified data
SM 13F filer · REGENERON PHARMACEUTICALS, INC. · REGENERON PHARMACEUTICALS
○ Watch REGN○ Watch filer
Side SELL
Δ value $7.88M
Shares 15.0K
Price $525
Executed Not disclosed
Disclosed Nov 3, 2025 Customize layout
REGN · daily Yahoo Finance chart API
◉ This trade, on the day it was made▼ Disclosure● Material company filing◯ Other disclosed buy◯ Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Insider Score Experimental signal Transaction type +12 / 20
EXIT
Relative size +2 / 25
$7.9M quarter-over-quarter change
Filing timing 0 / 15
Not applicable — 13F reports quarter-end holdings, execution dates are not disclosed
Historical behavior +8 / 15
First recorded trade by this actor in this security
Frequency & clustering +5 / 15
1 other actor traded the same direction within 14 days
Market events 0 / 10
No material company filing within 60 days after the trade
Other disclosed activity · REGN Score Actor Security Side Value Executed Disclosed Lag Source Evidence 29 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $33K 35 sh
Nov 4, 2026 Nov 6, 2026
Verified data Read directly from the primary public document; every field below is as reported by the filer.
Source
Publisher U.S. Securities and Exchange Commission (EDGAR)
Document ID 0001649339-25-000007 Timestamps
Event (reported) Not reported
Published Nov 3, 2025
Ingested by INSIDER Nov 4, 22:39 UTC
Last re-read Nov 10, 08:27 UTC Extracted facts
Filer Scion Asset Management, LLC
Role 13F filer
Transaction EXIT
Asset REGENERON PHARMACEUTICALS
Ticker REGN
Shares 15.0K
Price per share $525
Value $7,875,000
Owned after transaction 0 shares What this establishes Scion Asset Management, LLC reported this position change in a quarterly 13F holdings report. 13F shows quarter-end positions only — it does not say when during the quarter shares were bought or sold.
Extraction
Method 13F information table XML
Confidence 1.00
13F filer Scion Asset Management, LLCcik:0001649339
Issuer REGENERON PHARMACEUTICALS, INC.cik:0000872589 Revision history · 0 No field has changed since this record was first ingested.
No records No material filings recorded for this issuer.
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
39 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $499K 529 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
2 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M — 1,478 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
39 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $925K 982 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
39 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $412K 439 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
14 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M — 1,500 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
16 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M $953K 1,478 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
42 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $1.14M 1,215 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
32 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $102K 108 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
19 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M $1.09M 1,500 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
44 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $170K 179 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
39 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $541K 575 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
12 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M $445K 905 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
2 PJ Pitofsky Jason SVP Controller
REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M — 905 sh
Nov 4, 2026 Nov 6, 2026traded Nov 4, 2026
+2d SEC Form 4 Evidence
Evidence Close
57 REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $6.73M 6,939 sh
Nov 3, 2026 Nov 5, 2026traded Nov 3, 2026
+2d SEC Form 4 Evidence
Evidence Close
5 MJ Murphy Andrew J Co-Chief Scientific Officer
REGN REGENERON PHARMACEUTICALS, INC. Gift
G — 1,054 sh
Nov 3, 2026 Nov 5, 2026traded Nov 3, 2026
+2d SEC Form 4 Evidence
Evidence Close
30 REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M $2.83M 7,439 sh
Nov 3, 2026 Nov 5, 2026traded Nov 3, 2026
+2d SEC Form 4 Evidence
Evidence Close
50 REGN REGENERON PHARMACEUTICALS, INC. Open-market sale
SELL $486K 500 sh
Nov 3, 2026 Nov 5, 2026traded Nov 3, 2026
+2d SEC Form 4 Evidence
Evidence Close
9 REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M — 7,439 sh
Nov 3, 2026 Nov 5, 2026traded Nov 3, 2026
+2d SEC Form 4 Evidence
Evidence Close
9 REGN REGENERON PHARMACEUTICALS, INC. Option exercise
M — 7,830 sh
Nov 2, 2026 Nov 4, 2026traded Nov 2, 2026
+2d SEC Form 4 Evidence
Evidence Close
